Related Articles
Hypoxia increases the heterogeneity of melanoma cell populations and affects the response to vemurafenib
Phenotype characterization of human melanoma cells resistant to dabrafenib
Targeting the PI3K/AKT/mTOR pathway overcomes the stimulating effect of dabrafenib on the invasive behavior of melanoma cells with acquired resistance to the BRAF inhibitor
Umbilical cord‑derived mesenchymal stem cells can inhibit the biological functions of melanoma A375 cells
Kinase inhibitor screening identifies CDK4 as a potential therapeutic target for melanoma